Extending MET-TRIB3 axis research in hepatocellular carcinoma: Immune contexture and patient subgroups: Letter to the editor on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”

Clinical and Molecular Hepatology 2026 Open access

Read full text
Authors: Lei Wu, N. Liu, Pengyuan Song, Meili Sun
DOI: 10.3350/cmh.2025.1357
Cited by: 0

Abstract

Extending MET-TRIB3 axis research in hepatocellular carcinoma: Immune contexture and patient subgroups: Letter to the editor on "MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation"

Fields of Study & Subjects

FOXO transcription factor regulation Hepatocellular Carcinoma Treatment and Prognosis Fibroblast Growth Factor Research

Publication details

Journal / source
Clinical and Molecular Hepatology
Volume
32
Issue
3
Pages
e279–e282
Publication date
19 January 2026
Language
EN